drugset / Trial / NCT06757504
Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multi-center, randomized, double-blind, multiple dose levels, parallal group, placebo-controlled study, to evaluate the safety, PK profiles and preliminary efficacy of TTYP01 tablets in adolescents and children with ASD.
Timeline
- Start
- 2025-01-13
- Primary completion
- 2026-02-06
- Completion
- 2026-05-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TTYP01 | Unknown | 12 mg | Oral |
| Subject | TTYP01 | Unknown | 18 mg | Oral |
| Subject | TTYP01 | Unknown | 24 mg | Oral |
| Subject | TTYP01 | Unknown | 30 mg | Oral |
| Subject | TTYP01 | Unknown | 60 mg | Oral |